WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹68 Cr | ₹72 Cr | ₹23 Cr | ₹32 Cr | ₹16 Cr |
What is the latest Operating Profit of WANBURY ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹72 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹16 Cr |
How is Operating Profit of WANBURY Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 Cr | -6.10 | |
| Mar2024 | ₹72 Cr | 212.39 | |
| Mar2023 | ₹23 Cr | -27.28 | |
| Mar2022 | ₹32 Cr | 102.52 | |
| Mar2021 | ₹16 Cr | - | |
Compare Operating Profit of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,036.9 Cr | 4.5% | 14.6% | 1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 4.5% |
14.6% |
1.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses